Intravitreal dexamethasone implant for acute exudative polymorphous vitelliform maculopathy

Andrea Scupola; Edoardo Abed; Maria Grazia Sammarco; Salvatore Traina; Antonio Villano; Gabriela Grimaldi; Maria Antonietta Blasi

doi:10.5301/ejo.5000477

Intravitreal dexamethasone implant for acute exudative polymorphous vitelliform maculopathy

Andrea Scupola, Edoardo Abed, Maria Grazia Sammarco, Salvatore Traina, Antonio Villano, Gabriela Grimaldi, Maria Antonietta Blasi

Università Cattolica del Sacro Cuore

Risultato della ricerca: Contributo in rivista › Articolo in rivista

5 Citazioni (Scopus)

Abstract

Acute exudative polymorphous vitelliform maculopathy is a rare retinal disease characterized by bilateral serous macular detachment and subretinal accumulation of yellowish deposits resembling Best dystrophy lesions. Corticosteroid systemic therapy has been used empirically in the attempt to treat this retinal disorder with mixed results. Thus, the benefit of corticosteroid remains undetermined. To our knowledge, we report the first case of acute exudative polymorphous vitelliform maculopathy (AEPVM) treated in one eye with intravitreal dexamethasone implant (Ozurdex; Allergan, Inc., Irvine, California, USA).

Lingua originale	English
pagine (da-a)	803-807
Numero di pagine	5
Rivista	European Journal of Ophthalmology
Volume	24
DOI	https://doi.org/10.5301/ejo.5000477
Stato di pubblicazione	Pubblicato - 2014

Keywords

Acute Disease
Adult
Coloring Agents
Dexamethasone
Drug Implants
Exudates and Transudates
Fluorescein Angiography
Glucocorticoids
Humans
Indocyanine Green
Male
Tomography, Optical Coherence
Visual Acuity
Vitelliform Macular Dystrophy
Vitreous Body

Accesso al documento

10.5301/ejo.5000477

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{cb59e01a248b4e18a1acc5cf01add7e2,

title = "Intravitreal dexamethasone implant for acute exudative polymorphous vitelliform maculopathy",

abstract = "Acute exudative polymorphous vitelliform maculopathy is a rare retinal disease characterized by bilateral serous macular detachment and subretinal accumulation of yellowish deposits resembling Best dystrophy lesions. Corticosteroid systemic therapy has been used empirically in the attempt to treat this retinal disorder with mixed results. Thus, the benefit of corticosteroid remains undetermined. To our knowledge, we report the first case of acute exudative polymorphous vitelliform maculopathy (AEPVM) treated in one eye with intravitreal dexamethasone implant (Ozurdex; Allergan, Inc., Irvine, California, USA).",

keywords = "Acute Disease, Adult, Coloring Agents, Dexamethasone, Drug Implants, Exudates and Transudates, Fluorescein Angiography, Glucocorticoids, Humans, Indocyanine Green, Male, Tomography, Optical Coherence, Visual Acuity, Vitelliform Macular Dystrophy, Vitreous Body, Acute Disease, Adult, Coloring Agents, Dexamethasone, Drug Implants, Exudates and Transudates, Fluorescein Angiography, Glucocorticoids, Humans, Indocyanine Green, Male, Tomography, Optical Coherence, Visual Acuity, Vitelliform Macular Dystrophy, Vitreous Body",

author = "Andrea Scupola and Edoardo Abed and Sammarco, {Maria Grazia} and Salvatore Traina and Antonio Villano and Gabriela Grimaldi and Blasi, {Maria Antonietta}",

year = "2014",

doi = "10.5301/ejo.5000477",

language = "English",

volume = "24",

pages = "803--807",

journal = "European Journal of Ophthalmology",

issn = "1120-6721",

publisher = "Wichtig Publishing Srl",

}

TY - JOUR

T1 - Intravitreal dexamethasone implant for acute exudative polymorphous vitelliform maculopathy

AU - Scupola, Andrea

AU - Abed, Edoardo

AU - Sammarco, Maria Grazia

AU - Traina, Salvatore

AU - Villano, Antonio

AU - Grimaldi, Gabriela

AU - Blasi, Maria Antonietta

PY - 2014

Y1 - 2014

N2 - Acute exudative polymorphous vitelliform maculopathy is a rare retinal disease characterized by bilateral serous macular detachment and subretinal accumulation of yellowish deposits resembling Best dystrophy lesions. Corticosteroid systemic therapy has been used empirically in the attempt to treat this retinal disorder with mixed results. Thus, the benefit of corticosteroid remains undetermined. To our knowledge, we report the first case of acute exudative polymorphous vitelliform maculopathy (AEPVM) treated in one eye with intravitreal dexamethasone implant (Ozurdex; Allergan, Inc., Irvine, California, USA).

AB - Acute exudative polymorphous vitelliform maculopathy is a rare retinal disease characterized by bilateral serous macular detachment and subretinal accumulation of yellowish deposits resembling Best dystrophy lesions. Corticosteroid systemic therapy has been used empirically in the attempt to treat this retinal disorder with mixed results. Thus, the benefit of corticosteroid remains undetermined. To our knowledge, we report the first case of acute exudative polymorphous vitelliform maculopathy (AEPVM) treated in one eye with intravitreal dexamethasone implant (Ozurdex; Allergan, Inc., Irvine, California, USA).

KW - Acute Disease

KW - Adult

KW - Coloring Agents

KW - Dexamethasone

KW - Drug Implants

KW - Exudates and Transudates

KW - Fluorescein Angiography

KW - Glucocorticoids

KW - Humans

KW - Indocyanine Green

KW - Male

KW - Tomography, Optical Coherence

KW - Visual Acuity

KW - Vitelliform Macular Dystrophy

KW - Vitreous Body

KW - Acute Disease

KW - Adult

KW - Coloring Agents

KW - Dexamethasone

KW - Drug Implants

KW - Exudates and Transudates

KW - Fluorescein Angiography

KW - Glucocorticoids

KW - Humans

KW - Indocyanine Green

KW - Male

KW - Tomography, Optical Coherence

KW - Visual Acuity

KW - Vitelliform Macular Dystrophy

KW - Vitreous Body

UR - http://hdl.handle.net/10807/63456

U2 - 10.5301/ejo.5000477

DO - 10.5301/ejo.5000477

M3 - Article

SN - 1120-6721

VL - 24

SP - 803

EP - 807

JO - European Journal of Ophthalmology

JF - European Journal of Ophthalmology

ER -

Intravitreal dexamethasone implant for acute exudative polymorphous vitelliform maculopathy

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo